293 related articles for article (PubMed ID: 16556896)
21. A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study.
Zanon E; Pasca S; Sottilotta G; Molinari AC; Ferretti A; Di Gregorio P; Pollio B; Pizzuti M; Notarangelo LD; Biasoli C; Cojutti P; Pea F; Simioni P; Peyvandi F
Blood Transfus; 2023 Jul; 21(4):350-355. PubMed ID: 36580025
[TBL] [Abstract][Full Text] [Related]
22. Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-B.
Dodt J; Pasternack R; Seitz R; Volkers P
Br J Haematol; 2016 Feb; 172(3):452-60. PubMed ID: 26516704
[TBL] [Abstract][Full Text] [Related]
23. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
24. Patient-centered approach to managing factor XIII deficiency.
Iyengar V; Montcrieff C; Pels S
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34531230
[TBL] [Abstract][Full Text] [Related]
25. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
26. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
[TBL] [Abstract][Full Text] [Related]
27. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography.
Nielsen VG; Gurley WQ; Burch TM
Anesth Analg; 2004 Jul; 99(1):120-123. PubMed ID: 15281516
[TBL] [Abstract][Full Text] [Related]
28. Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
Korte W
J Blood Med; 2014; 5():107-13. PubMed ID: 25031548
[TBL] [Abstract][Full Text] [Related]
29. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
Nielsen VG; Kirklin JK; Hoogendoorn H; Ellis TC; Holman WL
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):145-50. PubMed ID: 17287631
[TBL] [Abstract][Full Text] [Related]
30. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis.
Duval C; Ali M; Chaudhry WW; Ridger VC; Ariëns RA; Philippou H
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):308-16. PubMed ID: 26743168
[TBL] [Abstract][Full Text] [Related]
31. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography.
Schroeder V; Chatterjee T; Kohler HP
Thromb Res; 2001 Dec; 104(6):467-74. PubMed ID: 11755957
[TBL] [Abstract][Full Text] [Related]
32. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.
Souri M; Koseki-Kuno S; Takeda N; Degen JL; Ichinose A
Int J Hematol; 2008 Jan; 87(1):60-8. PubMed ID: 18224415
[TBL] [Abstract][Full Text] [Related]
33. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.
Souri M; Yokoyama C; Osaki T; Ichinose A
Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722
[TBL] [Abstract][Full Text] [Related]
35. Preclinical safety and pharmacokinetics of recombinant human factor XIII.
Ponce RA; Visich JE; Heffernan JK; Lewis KB; Pederson S; Lebel E; Andrews-Jones L; Elliott G; Palmer TE; Rogge MC
Toxicol Pathol; 2005; 33(4):495-506. PubMed ID: 16036868
[TBL] [Abstract][Full Text] [Related]
36. Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies.
Kun M; Szuber N; Katona É; Pénzes K; Bonnefoy A; Bécsi B; Erdődi F; Rivard GE; Muszbek L
Haemophilia; 2017 Jul; 23(4):590-597. PubMed ID: 28345289
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
38. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005.
Schroeder V; Durrer D; Meili E; Schubiger G; Kohler HP
Swiss Med Wkly; 2007 May; 137(19-20):272-8. PubMed ID: 17594539
[TBL] [Abstract][Full Text] [Related]
39. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
Jang MA; Park YS; Lee KO; Kim HJ
Blood Coagul Fibrinolysis; 2015 Jan; 26(1):46-9. PubMed ID: 25004025
[TBL] [Abstract][Full Text] [Related]
40. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review.
Ito Y; Tsuji S; Kasahara M; Tokoro S; Murakami T; Takayama H
J Obstet Gynaecol Res; 2024 Feb; 50(2):262-265. PubMed ID: 37875278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
